Related Experiment Video
Updated: May 28, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma
Steven Chuan-Hao Kao1, Nicola Armstrong, Bridget Condon
1Asbestos Diseases Research Institute, Bernie Banton Centre, Rhodes, New South Wales, Australia.
Background:
Malignant mesothelioma (MM) is an aggressive cancer of serosal membranes, mostly pleura. It is related to asbestos exposure and its incidence in most industrialized countries is projected to remain stable or to increase until 2020. Prognosis remains poor. Clinical prognostic scoring systems lack precision. No prognostic tissue markers are available. Aquaporin 1 (AQP1) is a cell membrane channel involved in water transport, cell motility, and proliferation. A blocker and an agonist are available.
Methods:
Two independent cohorts of MM were studied. Cohort 1 consisted of 80 consecutive patients who underwent radical surgery (extrapleural pneumonectomy [EPP]). Cohort 2 included 56 conservatively managed patients from another institution. Clinical information was obtained from files. Diagnoses were histologically verified. Immunohistochemical labeling for AQP1 was performed on tumor tissue and the percentage of positive cells was scored.
Results:
We demonstrated expression of AQP1 in normal and neoplastic mesothelium at the apical aspect of the cell, in keeping with a role in water transport. For both cohorts, expression of AQP1 by ≥50% of tumor cells was associated with significantly enhanced survival (9.4 months vs 30.4 months in EPP patients and 5 months vs 15 months in conservatively treated patients). This was independent of established prognostic factors, including histologic subtype, pathologic stage, sex, and age at time of diagnosis.
Conclusion:
Expression of AQP1 correlated significantly with prognosis in MM, irrespective of treatment or established prognostic factors. Immunohistochemical labeling for AQP1 should be included in the routine histopathologic workup. An agonist or blocker may become useful for treatment.
Insights
High expression of Aquaporin 1 (AQP1) in malignant mesothelioma (MM) tumors indicates better patient survival. This prognostic marker is independent of other factors and could guide treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Malignant mesothelioma (MM) is an aggressive cancer with poor prognosis and no reliable tissue markers.
- Aquaporin 1 (AQP1), a water channel protein, is implicated in cell motility and proliferation.
- Current prognostic scoring systems for MM lack precision.
Purpose of the Study:
- To investigate the prognostic value of Aquaporin 1 (AQP1) expression in malignant mesothelioma (MM).
- To determine if AQP1 expression can serve as a predictive biomarker for MM patient survival.
- To assess the potential of AQP1 as a therapeutic target.
Main Methods:
- Studied two independent cohorts of MM patients (n=80 surgically treated, n=56 conservatively managed).
- Performed immunohistochemical labeling for AQP1 on tumor tissues.
- Scored the percentage of AQP1-positive tumor cells and correlated with clinical data.
Main Results:
- AQP1 was expressed in normal and neoplastic mesothelium, consistent with its role in water transport.
- High AQP1 expression (≥50% of tumor cells) significantly correlated with enhanced survival in both patient cohorts.
- This association remained significant regardless of established prognostic factors like histology, stage, sex, and age.
Conclusions:
- AQP1 expression is a significant and independent prognostic biomarker in malignant mesothelioma.
- Immunohistochemical assessment of AQP1 should be integrated into routine histopathologic evaluation of MM.
- AQP1-targeting agents (agonists or blockers) may offer future therapeutic strategies for MM.
Related Concept Videos
Aquaporins
Abnormal Proliferation

